Burlington, MA, United States of America

Flexion Therapeutics, Inc.


USPTO Granted Patents = 6



Trademarks = 3

Forward Citations = 7

Loading Chart...
Loading Chart...

13 inventors (with patents filed for the assignee):

goldMedal Neil Bodick (6 out of 7 patents)

silverMedal Robert C Blanks (5 out of 13 patents)

bronzeMedal Anjali Kumar (5 out of 5 patents)

4.  Mark Moran (5 out of 12 patents)

5.  Michael D Clayman (5 out of 5 patents)

6.  Rebecca Senter (1 out of 2 patents)

7.  Kris Wang (1 out of 1 patent)

8.  John Derek Jackson (1 out of 2 patents)

9.  Scott Kelley (1 out of 2 patents)

10.  Mark Douglas (1 out of 1 patent)

11.  Won Hong (1 out of 1 patent)

12.  Emily Walsh Martin (1 out of 1 patent)

13.  Monika Chabicovsky (1 out of 1 patent)


6 patents:

Company Overview
Flexion Therapeutics, Inc. is a biopharmaceutical company focused on the development and commercialization of novel, local therapies for the treatment of patients with musculoskeletal conditions. Their lead product, ZILRETTA, is an extended-release intra-articular injection approved for the management of osteoarthritis pain of the knee. Flexion Therapeutics is dedicated to improving the lives of patients suffering from chronic pain through innovative therapies.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

6 Patents

#63 in Burlington, MA

#2,546 in Massachusetts

#45,007 in US

Burlington, MA (US)
Burlington, MA, United States of America
Forward Citations = 7

13 inventors:

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Flexion Therapeutics, Inc.. Retrieved from https://idiyas.com/company/flexion-therapeutics

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…